Anand Prasad1, Paul Clopton1, Colby Ayers1, Amit Khera1, James A de Lemos1, Joseph L Witztum1, Sotirios Tsimikas2. 1. From the Division of Cardiology, Department of Medicine, The University of Texas Health Science Center San Antonio (A.P.); Veterans Affairs Medical Center, San Diego, CA (P.C.); Division of Cardiology, University of Texas Southwestern Medical Center at Dallas (C.A., A.K., J.A.d.L.); Division of Endocrinology and Metabolism (J.L.W.) and Department of Medicine (S.T.), University of California San Diego, La Jolla; and Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, La Jolla, CA (S.T.). 2. From the Division of Cardiology, Department of Medicine, The University of Texas Health Science Center San Antonio (A.P.); Veterans Affairs Medical Center, San Diego, CA (P.C.); Division of Cardiology, University of Texas Southwestern Medical Center at Dallas (C.A., A.K., J.A.d.L.); Division of Endocrinology and Metabolism (J.L.W.) and Department of Medicine (S.T.), University of California San Diego, La Jolla; and Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, La Jolla, CA (S.T.). stsimikas@ucsd.edu.
Abstract
OBJECTIVE: Modifications of lipid constituents within atherosclerotic lesions generate neoepitopes that activate innate and adaptive immune responses. We aimed to define the prevalence, distribution, and relationship of autoantibody titers of oxidized lipoproteins to subclinical atherosclerosis and major adverse cardiovascular events (MACE) in different ethnic groups. APPROACH AND RESULTS: IgG and IgM autoantibodies to malondialdehyde-modified low-density lipoprotein (MDA-LDL) and apolipoprotein B-100-immune complexes were measured in 3509 individuals (1814 blacks, 1031 whites, 589 Hispanics, and 85 no race identifier) from the Dallas Heart Study with median 10.5-year follow-up. Coronary artery calcium score, abdominal aortic plaque by magnetic resonance imaging, and MACE were quantified. IgG MDA-LDL and IgG and IgM apolipoprotein B-100-immune complexes were significantly different between groups, with blacks having the highest levels of IgG MDA-LDL and IgG apolipoprotein B-100-immune complexes and Hispanics having the highest levels of IgM apolipoprotein B-100-immune complexes (P<0.001 for all). IgGs tended to be higher and IgMs lower with age for all markers. In multivariable-adjusted binary logistic regression analysis, a doubling of IgG MDA-LDL levels was associated with prevalent coronary artery calcium score >10 Agatston units (odds ratio [95% confidence interval], 1.21 [1.07-1.36]; P=0.002). Multivariable-adjusted Cox regression analysis revealed that IgG MDA-LDL was independently associated with time to incident MACE in the entire group (hazard ratio [95% confidence interval], 1.76 [1.16-2.72]; P=0.009 for fourth versus first quartile). This effect was particularly prominent in black subjects (hazard ratio [95% confidence interval], 2.52 [1.39-4.57]; P=0.002). CONCLUSIONS: Autoantibodies to oxidized lipoproteins and immune complexes with apoB-100 lipoproteins vary significantly by sex, age, and ethnicity. Higher baseline IgG MDA-LDL titers independently associate with new MACE. These findings may contribute to the understanding of differences in ethnic-specific MACE events.
OBJECTIVE: Modifications of lipid constituents within atherosclerotic lesions generate neoepitopes that activate innate and adaptive immune responses. We aimed to define the prevalence, distribution, and relationship of autoantibody titers of oxidized lipoproteins to subclinical atherosclerosis and major adverse cardiovascular events (MACE) in different ethnic groups. APPROACH AND RESULTS: IgG and IgM autoantibodies to malondialdehyde-modified low-density lipoprotein (MDA-LDL) and apolipoprotein B-100-immune complexes were measured in 3509 individuals (1814 blacks, 1031 whites, 589 Hispanics, and 85 no race identifier) from the Dallas Heart Study with median 10.5-year follow-up. Coronary artery calcium score, abdominal aortic plaque by magnetic resonance imaging, and MACE were quantified. IgG MDA-LDL and IgG and IgM apolipoprotein B-100-immune complexes were significantly different between groups, with blacks having the highest levels of IgG MDA-LDL and IgG apolipoprotein B-100-immune complexes and Hispanics having the highest levels of IgM apolipoprotein B-100-immune complexes (P<0.001 for all). IgGs tended to be higher and IgMs lower with age for all markers. In multivariable-adjusted binary logistic regression analysis, a doubling of IgG MDA-LDL levels was associated with prevalent coronary artery calcium score >10 Agatston units (odds ratio [95% confidence interval], 1.21 [1.07-1.36]; P=0.002). Multivariable-adjusted Cox regression analysis revealed that IgG MDA-LDL was independently associated with time to incident MACE in the entire group (hazard ratio [95% confidence interval], 1.76 [1.16-2.72]; P=0.009 for fourth versus first quartile). This effect was particularly prominent in black subjects (hazard ratio [95% confidence interval], 2.52 [1.39-4.57]; P=0.002). CONCLUSIONS: Autoantibodies to oxidized lipoproteins and immune complexes with apoB-100 lipoproteins vary significantly by sex, age, and ethnicity. Higher baseline IgG MDA-LDL titers independently associate with new MACE. These findings may contribute to the understanding of differences in ethnic-specific MACE events.
Authors: Athanasios I Papathanasiou; Evangelia S Lourida; Loukas D Tsironis; John A Goudevenos; Alexandros D Tselepis Journal: Atherosclerosis Date: 2006-11-30 Impact factor: 5.162
Authors: Fangwen Rao; Andrew J Schork; Adam X Maihofer; Caroline M Nievergelt; Santica M Marcovina; Elizabeth R Miller; Joseph L Witztum; Daniel T O'Connor; Sotirios Tsimikas Journal: Arterioscler Thromb Vasc Biol Date: 2015-05-07 Impact factor: 8.311
Authors: S A Karabina; M C Elisaf; J Goudevenos; K C Siamopoulos; D Sideris; A D Tselepis Journal: Atherosclerosis Date: 1996-08-23 Impact factor: 5.162
Authors: Maurizio Bossola; Luigi Tazza; Esther Merki; Stefania Giungi; Giovanna Luciani; Elizabeth R Miller; Edward B Lin; Antonio Tortorelli; Sotirios Tsimikas Journal: Blood Purif Date: 2007-12-13 Impact factor: 2.614
Authors: Gian Paolo Rossi; Maurizio Cesari; Renzo De Toni; Mario Zanchetta; Giuseppe Maiolino; Luigi Pedon; Chiara Ganzaroli; Pietro Maiolino; Achille C Pessina Journal: Circulation Date: 2003-10-27 Impact factor: 29.690
Authors: Calvin Yeang; Devin Hasanally; Xuchu Que; Ming-Yow Hung; Aleksandra Stamenkovic; David Chan; Rakesh Chaudhary; Victoria Margulets; Andrea L Edel; Masahiko Hoshijima; Yusu Gu; William Bradford; Nancy Dalton; Phuong Miu; David Yc Cheung; Davinder S Jassal; Grant N Pierce; Kirk L Peterson; Lorrie A Kirshenbaum; Joseph L Witztum; Sotirios Tsimikas; Amir Ravandi Journal: Cardiovasc Res Date: 2019-01-01 Impact factor: 10.787
Authors: Maria F Lopes-Virella; Ionut Bebu; Kelly J Hunt; Gabriel Virella; Nathaniel L Baker; Barbara Braffett; Xiaoyu Gao; John M Lachin Journal: Diabetes Date: 2019-06-19 Impact factor: 9.461
Authors: Payel Roy; John Sidney; Cecilia S Lindestam Arlehamn; Elizabeth Phillips; Simon Mallal; Sujit Silas Armstrong Suthahar; Monica Billitti; Paul Rubiro; Daniel Marrama; Fabrizio Drago; Jenifer Vallejo; Vasantika Suryawanshi; Marco Orecchioni; Jeffrey Makings; Paul J Kim; Coleen A McNamara; Bjoern Peters; Alessandro Sette; Klaus Ley Journal: Circ Res Date: 2022-06-29 Impact factor: 23.213
Authors: Victor J van den Berg; Dorian O Haskard; Artur Fedorowski; Adam Hartley; Isabella Kardys; Mikhail Caga-Anan; K Martijn Akkerhuis; Rohit M Oemrawsingh; Robert Jan van Geuns; Peter de Jaegere; Nicolas van Mieghem; Evelyn Regar; Jurgen M R Ligthart; Victor A W M Umans; Patrick W Serruys; Olle Melander; Eric Boersma; Ramzi Y Khamis Journal: EBioMedicine Date: 2018-08-18 Impact factor: 8.143